🇺🇸 FDA
Pipeline program

LVIVO-TaVec400 product

LB2505-0002

Phase 1 mab active

Quick answer

LVIVO-TaVec400 product for Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE) is a Phase 1 program (mab) at Legend Biotech Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
Legend Biotech Corp
Indication
Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE)
Phase
Phase 1
Modality
mab
Status
active

Clinical trials